Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 12 di 12
Titolo Data di pubblicazione Autore(i) File
Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease 1-gen-2010 Ambrosi, G.; Armentero, M. -T.; Levandis, G.; Bramanti, P.; Nappi, G.; Blandini, F.
Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease 1-gen-2011 Armentero, M. T.; Sinforiani, E.; Ghezzi, C.; Bazzini, E.; Levandis, G.; Ambrosi, G.; Zangaglia, R.; Pacchetti, C.; Cereda, C.; Cova, E.; Basso, E.; Celi, D.; Martignoni, E.; Nappi, G.; Blandini, F.
SOD1 and DJ-1 converge at Nrf2 pathway: A clue for antioxidant therapeutic potential in neurodegeneration 1-gen-2013 Milani, P.; Ambrosi, G.; Gammoh, O.; Blandini, F.; Cereda, C.
Fibroblasts from skin biopsies as a tool for biomarker discovery in Parkinson׳s disease 1-gen-2014 Mastroberardino, Pier Giorgio; Ambrosi, Giulia; Blandini, Fabio; Milanese, Chiara; Sepe, Sara
Neuroprotective potential of adenosine A2A and cannabinoid CB1 receptor antagonists in an animal model of Parkinson disease 1-gen-2014 Cerri, S.; Levandis, G.; Ambrosi, G.; Montepeloso, E.; Antoninetti, G. F.; Franco, R.; Lanciego, J. L.; Baqi, Y.; Muller, C. E.; Pinna, A.; Blandini, F.; Armentero, M. T.
A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease 1-gen-2014 Ambrosi, G.; Cerri, S.; Blandini, F.
Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson's disease 1-gen-2014 Ambrosi, G.; Ghezzi, C.; Sepe, S.; Milanese, C.; Payan-Gomez, C.; Bombardieri, C. R.; Armentero, M. -T.; Zangaglia, R.; Pacchetti, C.; Mastroberardino, P. G.; Blandini, F.
Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: Relevance to gastrointestinal dysfunctions in Parkinson's disease 1-gen-2015 Levandis, Giovanna; Balestra, Barbara; Siani, F.; Rizzo, Vittoria; Ghezzi, Cristina; Ambrosi, Giulia; Cerri, Silvia; Bonizzi, Alberto; Vicini, Riccardo; Vairetti, Mariapia; Ferrigno, Andrea; Pastoris, Ornella; Blandini, Fabio
Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells 1-gen-2015 Ambrosi, G.; Ghezzi, C.; Zangaglia, R.; Levandis, G.; Pacchetti, C.; Blandini, F.
Dual target strategy: Combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l -DOPA-induced rotational behavior in a rodent model of Parkinson's disease 1-gen-2015 Fuzzati-Armentero, M. -T.; Cerri, S.; Levandis, G.; Ambrosi, G.; Montepeloso, E.; Antoninetti, G.; Blandini, F.; Baqi, Y.; Muller, C. E.; Volpini, R.; Costa, G.; Simola, N.; Pinna, A.
Selective blockade of mGlu5 metabotropic glutamate receptors is protective against hepatic mitochondrial dysfunction in 6-OHDA lesioned Parkinsonian rats 1-gen-2015 Ferrigno, Andrea; Vairetti, Mariapia; Ambrosi, Giulia; Rizzo, Vittoria; Richelmi, Plinio; Blandini, Fabio; Fuzzati Armentero, Marie Therese
Repurposing opportunities for Parkinson’s disease therapies 1-gen-2017 Ambrosi, G.; Cerri, S.; Blandini, F.
Mostrati risultati da 1 a 12 di 12
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile